Ligand · GIN

GIN · 2-{[(6-oxo-1,6-dihydropyridin-3-yl)methyl]amino}-N-[4-propyl-3-(trifluoromethyl)phenyl]benzamide

GIN, 2-{[(6-oxo-1,6-dihydropyridin-3-yl)methyl]amino}-N-[4-propyl-3-(trifluoromethyl)phenyl]benzamide (C23 H22 F3 N3 O2, 429.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with its…

Component: GIN
Formula: C23 H22 F3 N3 O2
Class: ligand
Structures: 2
PDB entries: 1

Binding sites

GIN in 2 structures; the first of them:

2HZ0 · Abl kinase domain in complex with NVP-AEG082 · GIN A600 · binds LEU248, VAL256, ALA269, VAL270, LYS271, GLU286, VAL289, MET290 and 19 more
2HZ0 · Abl kinase domain in complex with nvp-AEG082 · GIN A600 · binds LEU248, VAL256, ALA269, VAL270, LYS271, GLU286, VAL289, MET290 and 19 more

Residues it binds most

VAL 4, LEU 4, ILE 4, PHE 4, ALA 4, GLU 4, MET 4, ASP 4, HIS 4, LYS 4 (residue and the binding sites it lines).

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.